New tests may show how much value a particular obese patient will get for a GLP-1 agonist prescription dollar. Wegovy semaglutide injection pens. Credit: K KStock/Adobe Stock Two health technology ...

Medicare has announced 15 new drugs up for price negotiations, set to begin in the next several months with top drugmakers, ...

Nearly 60% of employees recently surveyed by technology platform Inclusively identify as having a disability but a large ...

The company uses public data sets, not secret information, to create out-of-network reimbursement recommendations, according ...

Whether it’s exploring new funding models, leveraging carrier innovations, or simplifying benefits delivery, advisors play a ...

In the latest Securities and Exchange Commission off-channel communications sweep, 12 firms will pay hefty fines because they ...

Top career regrets include not asking for a pay increase (6%), not prioritizing work-life balance (59%), staying at a job too ...

At one large self-funded plan, provider shortages pushed more than 37% of the patients to get their behavioral health care ...

Here are 10 tips to help build a more diverse industry. Many benefits professionals are passionate about building a more ...

The Big Tech giants join a growing list of employers, including Walmart and McDonald’s, that are re-evaluating their ...

Andrew Witty, UnitedHealth CEO, said the move will remove an excuse other players use to blame Optum Rx for high drug costs.

The request comes in the wake of the murder of UHC CEO Brian Thompson in December.